Capstone Therapeutics Corp.
|
-36.39 USD
|
99.615%
|
Skye Bioscience, Inc.
|
-5.37 USD
|
97.393%
|
Santhera Pharmaceuticals Holding AG
|
5.95 USD
|
102.353%
|
Nascent Biotech, Inc.
|
-0.01 USD
|
-944.776%
|
Qrons Inc.
|
-0.06 USD
|
-140.137%
|
ProtoKinetix, Incorporated
|
-0.01 USD
|
-1300.0%
|
Adynxx, Inc.
|
- USD
|
Infinity%
|
Arch Therapeutics, Inc.
|
-2.27 USD
|
93.833%
|
BioStem Technologies, Inc.
|
-0.62 USD
|
77.419%
|
Regen BioPharma, Inc.
|
0.26 USD
|
153.846%
|
CSL Limited
|
2.73 USD
|
105.128%
|
Northwest Biotherapeutics, Inc.
|
-0.06 USD
|
-143.478%
|
Evofem Biosciences, Inc.
|
10.35 USD
|
101.353%
|
Rebus Holdings, Inc.
|
-0.03 USD
|
-336.137%
|
Burzynski Research Institute, Inc.
|
-0.01 USD
|
-1272.549%
|
Neon Bloom, Inc.
|
-0.00 USD
|
-9233.333%
|
Acro Biomedical Co., Ltd.
|
-0.26 USD
|
46.154%
|
Eiger BioPharmaceuticals, Inc.
|
-50.78 USD
|
99.724%
|
Nanobac Pharmaceuticals, Incorporated
|
- USD
|
Infinity%
|
Institute of Biomedical Research Corp.
|
-0.05 USD
|
-171.845%
|
SQZ Biotechnologies Company
|
-2.76 USD
|
94.928%
|
Intellipharmaceutics International Inc.
|
-0.09 USD
|
-60.183%
|
Propanc Biopharma, Inc.
|
-0.02 USD
|
-490.717%
|
Mesoblast Limited
|
-0.09 USD
|
-57.127%
|
Marizyme, Inc.
|
-1.44 USD
|
90.278%
|
Genus plc
|
0.12 USD
|
216.667%
|
VioQuest Pharmaceuticals, Inc.
|
-2.33 USD
|
93.991%
|
Pharming Group N.V.
|
-0.02 USD
|
-769.565%
|
Therapeutic Solutions International, Inc.
|
-0.00 USD
|
-19900.0%
|
CNBX Pharmaceuticals Inc.
|
-0.42 USD
|
66.667%
|
Nymox Pharmaceutical Corporation
|
-0.10 USD
|
-45.078%
|
ContraFect Corporation
|
-124.97 USD
|
99.888%
|
PsyBio Therapeutics Corp.
|
-0.04 USD
|
-233.333%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
-0.01 USD
|
-1066.667%
|
IMV Inc.
|
-4.37 USD
|
96.796%
|
AXIM Biotechnologies, Inc.
|
-0.04 USD
|
-295.48%
|
MultiCell Technologies, Inc.
|
-0.00 USD
|
-139900.0%
|
ONE Bio Corp.
|
1.43 USD
|
109.79%
|
Accustem Sciences Inc.
|
-0.34 USD
|
58.824%
|
RVL Pharmaceuticals plc
|
-0.58 USD
|
75.862%
|
Arno Therapeutics, Inc.
|
- USD
|
Infinity%
|
EV Biologics, Inc.
|
-0.12 USD
|
-16.667%
|
Q BioMed Inc.
|
-0.08 USD
|
-79.257%
|
Emmaus Life Sciences, Inc.
|
-0.07 USD
|
-99.147%
|
Mosaic ImmunoEngineering Inc.
|
-0.33 USD
|
57.576%
|
Biomind Labs Inc.
|
-0.02 USD
|
-764.198%
|
American Oriental Bioengineering, Inc.
|
-781.24 USD
|
99.982%
|
Provectus Biopharmaceuticals, Inc.
|
-0.01 USD
|
-1791.892%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
Infinity%
|
Oncotelic Therapeutics, Inc.
|
-0.02 USD
|
-603.518%
|
GlobeStar Therapeutics Corporation
|
-0.00 USD
|
-5733.333%
|
THC Farmaceuticals, Inc.
|
-0.00 USD
|
-17400.0%
|
Curative Biotechnology, Inc.
|
-0.01 USD
|
-1490.909%
|
GB Sciences, Inc.
|
-0.00 USD
|
-3314.634%
|
Alpha Cognition Inc.
|
-0.15 USD
|
6.667%
|
HST Global, Inc.
|
-0.03 USD
|
-401.792%
|
Wesana Health Holdings Inc.
|
-0.05 USD
|
-179.441%
|
Halberd Corporation
|
-0.00 USD
|
-139900.0%
|
Enzolytics Inc.
|
-0.00 USD
|
-19900.0%
|
Agentix Corp.
|
-0.04 USD
|
-300.0%
|
Resverlogix Corp.
|
-0.01 USD
|
-885.915%
|
Nuo Therapeutics, Inc.
|
-0.08 USD
|
-85.676%
|
MetaStat, Inc.
|
- USD
|
Infinity%
|
argenx SE
|
-5.16 USD
|
97.287%
|
Enzon Pharmaceuticals, Inc.
|
0.00 USD
|
10869.231%
|
Endonovo Therapeutics, Inc.
|
0.03 USD
|
657.769%
|
RespireRx Pharmaceuticals Inc.
|
-0.04 USD
|
-292.157%
|
GeneThera, Inc.
|
- USD
|
Infinity%
|
Inhibitor Therapeutics, Inc.
|
-0.02 USD
|
-600.0%
|
AVAX Technologies, Inc.
|
-0.05 USD
|
-159.74%
|
Zenith Capital Corp.
|
-0.07 USD
|
-100.286%
|
Genscript Biotech Corporation
|
-0.05 USD
|
-208.37%
|
Ember Therapeutics, Inc.
|
-0.01 USD
|
-2122.222%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
Sigyn Therapeutics, Inc.
|
-3.77 USD
|
96.286%
|
WPD Pharmaceuticals Inc.
|
-0.00 USD
|
-27900.0%
|
Cotinga Pharmaceuticals Inc.
|
-0.09 USD
|
-53.341%
|
Kadimastem Ltd
|
-0.78 USD
|
82.051%
|
Helix BioMedix, Inc.
|
-4.70 USD
|
97.021%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
Infinity%
|
Oncology Pharma Inc.
|
- USD
|
Infinity%
|
Reve Technologies, Inc.
|
-0.01 USD
|
-1076.471%
|
LadRx Corporation
|
0.68 USD
|
120.588%
|
Cell Source, Inc.
|
-0.17 USD
|
17.647%
|
Regen BioPharma, Inc.
|
0.29 USD
|
148.276%
|
NovAccess Global Inc.
|
-0.23 USD
|
39.13%
|
Affymax, Inc.
|
-0.39 USD
|
64.103%
|
Itoco Inc.
|
-0.01 USD
|
-1742.105%
|
Rasna Therapeutics, Inc.
|
-0.01 USD
|
-1300.0%
|
Pathfinder Cell Therapy, Inc.
|
-0.00 USD
|
-5500.0%
|
Mobile Lads Corp.
|
-0.01 USD
|
-2400.0%
|
CytoDyn Inc.
|
-0.05 USD
|
-164.65%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
NDT Pharmaceuticals Inc.
|
-0.00 USD
|
-27900.0%
|
NanoSphere Health Sciences Inc.
|
-0.02 USD
|
-530.631%
|
Alseres Pharmaceuticals, Inc.
|
-153.67 USD
|
99.909%
|
SYBLEU INC
|
-0.02 USD
|
-700.0%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
Infinity%
|
ImmunoCellular Therapeutics, Ltd.
|
-0.01 USD
|
-885.915%
|
International Stem Cell Corporation
|
-0.02 USD
|
-753.659%
|
Bioxytran, Inc.
|
-0.03 USD
|
-338.871%
|
GlobeImmune, Inc.
|
- USD
|
Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
Infinity%
|
ProText Mobility, Inc.
|
- USD
|
Infinity%
|
Cardax, Inc.
|
- USD
|
Infinity%
|
VG Life Sciences Inc.
|
-0.00 USD
|
-139900.0%
|
Kaleido Biosciences, Inc.
|
- USD
|
Infinity%
|
Advaxis, Inc.
|
-7.99 USD
|
98.248%
|
Adhera Therapeutics, Inc.
|
-1.18 USD
|
88.136%
|
RenovaCare, Inc.
|
- USD
|
Infinity%
|
Regnum Corp.
|
-0.03 USD
|
-311.765%
|
Innovation Pharmaceuticals Inc.
|
-0.01 USD
|
-2122.222%
|
Neutra Corp.
|
-0.00 USD
|
-139900.0%
|
Windtree Therapeutics, Inc.
|
-94.23 USD
|
99.851%
|
PureTech Health plc
|
-2.38 USD
|
94.118%
|
Coeptis Therapeutics, Inc.
|
-0.83 USD
|
83.133%
|
IXICO plc
|
-0.02 USD
|
-473.77%
|
IntelGenx Technologies Corp.
|
-0.06 USD
|
-146.479%
|
Gelesis Holdings, Inc.
|
-1.35 USD
|
89.63%
|
CSL Limited
|
5.47 USD
|
102.559%
|
Cellectis S.A.
|
-1.77 USD
|
92.09%
|